Adrian Krainer Archives - Cold Spring Harbor Laboratory

Newsstand Menu

Home / Newsstand / CSHL Stories

Select stories by tag

Adrian Krainer wins RNA Society’s Lifetime Achievement Award

March 8, 2019

Professor Adrian Krainer was awarded the RNA Society’s Lifetime Achievement Award for his life-saving research.

National Academy of Inventors Fellow, Adrian Krainer

December 11, 2018

Professor Adrian Krainer has been named a NAI 2018 Fellow for his work on the first FDA-approved treatment for spinal muscular atrophy.

Big bold dreamers

December 10, 2018

Dreamers drive discoveries. CSHL honors its many scientists making big impacts in their respective fields.

Breakthrough Prize laureates meet at CSHL

December 6, 2018

Breakthrough Prize winner Adrian Krainer & C. Frank Bennett reunite for the first time since their award ceremony at CSHL to discuss further project.

Breakthrough Prize to CSHL professor for SMA research

October 17, 2018

Professor Adrian Krainer has received a Breakthrough Prize in Life Sciences for his work on the first FDA-approved treatment of SMA.

Predicting how splicing errors impact disease risk

August 30, 2018

New research helps correlate genetic mutations with errors in RNA splicing that can cause serious illness

CSHL helps ring opening bell at Nasdaq

August 21, 2018

CSHL Professor Adrian Krainer and his team join the Spinal Muscular Atrophy (SMA) Foundation in ringing the Nasdaq opening bell

Therapeutic RNA corrects splicing defect that causes familial dysautonomia

April 30, 2018

A team provides proof of concept for an RNA drug correcting an error in RNA splicing that causes familial dysautonomia (FD)

New method identifies splicing biomarkers for liver cancer

March 2, 2018

Researchers have developed a method for identifying splicing-based biomarkers for liver cancer

Welcome to the real world of science, I’ll be your guide

February 5, 2018

Jackie Novatt was determined to show the people on her campus tours how science really works—and landed her dream job in the process.

FDA approval of life-saving SMA drug is hailed by its researcher-inventor at CSHL

December 24, 2016

Nusinersen (Spinraza) will be used to treat young children with a severe and potentially fatal illness called spinal muscular atrophy (SMA).

One experiment: A drug for SMA visibly repairs defective cells

December 1, 2016

Professor Adrian Krainer develops a treatment for spinal muscular atrophy, the leading genetic cause of infant death.

“Sink or swim”

October 15, 2016

This episode of Base Pairs follows Professor Adrian Krainer and his experience as the first CSHL fellow.

Candidate drug for spinal muscular atrophy, with roots in CSHL research, passes major hurdle

August 4, 2016

Biotechnology firms Biogen and Ionis Pharmaceuticals cut short a phase-3 clinical trial for the investigational drug nusinersen as it met endpoint.

Adrian Krainer of Cold Spring Harbor Laboratory elected to American Academy of Arts and Sciences

April 20, 2016

Adrian Krainer was elected to the American Academy of Arts and Sciences.

CSHL Story archive for Tag: Adrian Krainer